Product License Update (BoNT-A)

Product License Update (BoNT-A)

CSP announces major change for qualified healthcare injectors in focal spasticity.A product licence update for the botulinum toxin-A (BoNT-A) medicine Dysport® has been granted and this is now clear that it can be administered by any appropriately trained and...